Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue, net	$ 3,425	$ 3,176
Cost of product revenue (excluding $1,528 in intangible asset amortization for the three months ended March 31, 2024, shown separately below)	175	125
Intangible asset amortization	1,528	0
Operating expenses:
Research and development	12,277	8,655
Selling, general and administrative	9,931	7,227
Total operating expenses	22,208	15,882
Loss from operations	(20,486)	(12,831)
Other income (expense):
Interest expense	(735)	(182)
Fair value adjustment related to warrant and CVR liability	3,627	(1,545)
Fair value adjustment related to investments	(27)	196
Interest and other income, net	929	1,042
Total other income (expense)	3,794	(489)
Loss before income taxes	(16,692)	(13,320)
Income tax benefit	70	103
Net loss	$ (16,622)	$ (13,217)
Basic and diluted net loss per share of common stock:
Net loss (in dollars per share)	$ (0.4)	$ (0.38)
Weighted average number of shares of common stock outstanding:
Basic and diluted (in shares)	41,778,774	34,466,542